Fiasp (insulin aspart)

pCPA File Number: 21023
Negotiation Status:
Concluded without agreement
Indication(s):
Diabetes Mellitus, Type 1 & 2
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: